Chembio Diagnostics (CEMI) Misses Q3 EPS by 2c

November 10, 2016 8:53 AM EST
Get Alerts CEMI Hot Sheet
Trade CEMI Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Chembio Diagnostics (NASDAQ: CEMI) reported Q3 EPS of ($0.19), $0.02 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $3.75 million versus the consensus estimate of $3.76 million.

For earnings history and earnings-related data on Chembio Diagnostics (CEMI) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment